Transaction · 0001628280-26-058684

Hayden Michael R

Hayden Michael R, DIR, reported an open-market or private purchase at AbCellera Biologics Inc. involving 53613.000000 shares for an estimated $570442.32. Reported holdings after the transaction were 1373397.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PDIR
ABCLAbCellera Biologics Inc.
Trade date
Aug 24, 2026
Filing date
Aug 24, 2026
View on SEC Insider profile
Estimated value$570kShares × reported price
Shares traded53.6k$10.64 per share
Holdings after1.37MIndirect · See footnote
% of reported position traded4.06%This security and ownership context
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 1,319,784 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ABCL price since this filing

Daily closing prices, with the filing date and available return windows
ABCL · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -50.0%1w ago +5.6%1d ago +6.7%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001628280-26-058684
Common Shares
Transaction date
Aug 24, 2026
Filed Aug 24, 2026, 09:21 PM · 0d delay
Shares
53,613 sh
$10.64 per share
Estimated value
$570k
Computed from shares × price
Holdings after
1,373,397 sh
Indirect · See footnote

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Buy Director Buy
Filing-only score

+36 points

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

How this score is calculated
  • open_market_purchase+12 points

    transaction_code = P

    Code P is a discretionary open-market purchase.
  • director_buy+6 points

    is_director = true

    Director open-market purchase.
  • cluster_buy+14 points

    cluster-buy signal matched

    Multiple insiders bought within the configured window.
  • timely_filing+4 points

    reporting_delay_days = 0

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $10.49 to $10.70. The reporting person undertakes to provide the…

  2. F2

    These shares are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. The reporting per…

Original filing · 0001628280-26-058684
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ABCL